Rutgers Institute for Nicotine and Tobacco Studies (INTS)
Rutgers INTS is a non-profit research institute within Rutgers University that conducts tobacco and nicotine regulatory science, surveillance, treatment, and policy research, serving the FDA, NIH, NJ Department of Health, clinicians, and New Jersey citizens.
- Company typePrivate
- Founded2000
- HeadquartersNew Brunswick, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Rutgers Institute for Nicotine and Tobacco Studies (INTS) does
The Rutgers Institute for Nicotine and Tobacco Studies (INTS) is a non-profit research institute embedded within Rutgers, The State University of New Jersey, headquartered at 303 George Street, 5th Floor, New Brunswick, NJ. Founded in 2000 as the Center for Tobacco Studies and rebranded to INTS in July 2023, the institute operates five specialized centers: the Tobacco Center of Regulatory Science (TCORS), which informs FDA tobacco regulation; the Center of Excellence for Rapid Surveillance of Tobacco (CRST), a real-time surveillance center funded by an $18M NIH grant; the Tobacco Dependence Program (TDP), a nationally accredited treatment and Tobacco Treatment Specialist training program; the Tobacco Industry Marketing (TIM) Program, home to the Trinkets & Trash surveillance archive; and the Tobacco Control Law and Policy Resource Center (TCLPRC), which provides legal and policy guidance to government bodies. INTS maintains core research infrastructure in the Office of Survey Methods and Data Analysis (SMDA) and produces recurring publications such as the NJ Youth Tobacco Survey and NJ Point-of-Sale Reports.
INTS's technology stack centers on survey methodology, statistical analysis, surveillance databases, and policy/regulatory science rather than commercial software products. Its proprietary assets include the Trinkets & Trash archive of tobacco marketing materials, multi-year NJ youth and point-of-sale datasets, and an FDA-facing regulatory science workflow. The institute has approximately 39 staff, including core faculty, research staff, trainees, and central administration.
INTS operates a grant-funded, non-commercial business model. Over its history it has been awarded approximately $75 million in extramural funding, primarily from the National Institutes of Health and the FDA, with recent major grants including TCORS 2.0 ($18M, 2018-2025) and CRST ($18M, 2023). Downstream mission outputs include treatment of over 7,000 smokers in New Jersey and TTS training of more than 3,000 clinicians across all 50 states and over 11 countries, but these are not monetized as standalone revenue streams. Customer segments are government funders (NIH, FDA, NJ DOH, NY State DOH), clinicians seeking training, and New Jersey smokers receiving treatment services.
Rutgers Institute for Nicotine and Tobacco Studies (INTS) firmographics
Firmographics- Name
- Rutgers Institute for Nicotine and Tobacco Studies (INTS)
- Legal name
- Rutgers Institute for Nicotine and Tobacco Studies, Rutgers, The State University of New Jersey
- Website
- https://ints.rutgers.edu
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Rutgers INTS is a non-profit research institute within Rutgers University that conducts tobacco and nicotine regulatory science, surveillance, treatment, and policy research, serving the FDA, NIH, NJ Department of Health, clinicians, and New Jersey citizens.
- Ownership category
- akta.pro rank
Rutgers Institute for Nicotine and Tobacco Studies (INTS) industry classification
Industry- Product category
- Tobacco Control Research and Public Health
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro industry
- Public Research Universities with Academic Medical Centers (AMCs)Research Administration & Compliance (Sponsored Programs, IRB/REB)Education/Education Administration, Accreditation & Policy/Institutional Governance & Administration (School/College/University Admin)Smoking Cessation & Nicotine Replacement Therapy (NRT)
Keywords
Where Rutgers Institute for Nicotine and Tobacco Studies (INTS) is headquartered
LocationHeadquarters
- HQ city
- New Brunswick
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Rutgers Institute for Nicotine and Tobacco Studies (INTS) business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Others
Revenue model
- Extramural Research Funding: INTS has been awarded approximately $75 million in extramural funding over the past two decades, primarily from federal sources including NIH and FDA.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Rutgers Institute for Nicotine and Tobacco Studies (INTS) product offering
Product offeringCore offering
The Rutgers Institute for Nicotine and Tobacco Studies (INTS) is a research institute that conducts tobacco control research, delivers evidence-based tobacco dependence treatment, trains clinicians as tobacco treatment specialists, and provides legal/policy guidance to government agencies. It operates five specialized centers (TCORS, CRST, TDP, TIM, TCLPRC) plus a central Office of Survey Methods and Data Analysis (SMDA).
Product overview
The Institute for Nicotine and Tobacco Studies (INTS) is a research institute offering a portfolio of interconnected research centers, treatment programs, and training services. The core research infrastructure includes five centers: the Tobacco Center of Regulatory Science (TCORS) which informs FDA tobacco regulation; the Center of Excellence for Rapid Surveillance of Tobacco (CRST) for real-time tobacco market monitoring; the Tobacco Industry Marketing (TIM) Program with its Trinkets & Trash surveillance archive; the Tobacco Control Law and Policy Resource Center (TCLPRC) for legal/policy guidance; and the Tobacco Dependence Program (TDP) for smoking cessation treatment. Supporting infrastructure includes the Office of Survey Methods and Data Analysis (SMDA) for methodological services, and a Tobacco Treatment Specialist training program accredited by CTTTP. The institute also produces recurring research publications including NJ Point-of-Sale Reports and NJ Youth Tobacco Survey Reports, and hosts monthly educational seminars.
Differentiator
Problem solved
Functional benefit
Brands
- Trinkets and Trash (T&T): A surveillance system and archive that monitors, collects, and documents current and historic tobacco products and tobacco industry marketing materials and tactics for research and educational purposes.
Products and services
- Tobacco Center of Regulatory Science (TCORS) Generates critical research to inform the FDA's regulation of tobacco products. Part of a national network of TCORS centers studying effects of tobacco marketing, labeling, and packaging on users and non-users.
- Center of Excellence for Rapid Surveillance of Tobacco (CRST) An $18 million grant-funded center enabling researchers to rapidly identify and analyze critical information in real time to generate timely information for FDA regulatory and enforcement action.
- Tobacco Dependence Program (TDP) Dedicated to reducing harm from tobacco use, providing expertise on quitting smoking. Includes a Council for Tobacco Treatment Training Programs (CTTTP) accredited Tobacco Treatment Specialist (TTS) Training program. Has treated over 7,000 smokers in New Jersey.
- Tobacco Industry Marketing (TIM) Program Monitors and documents tobacco industry marketing materials and tactics through the Trinkets & Trash surveillance system and archive.
- Tobacco Control Law and Policy Resource Center (TCLPRC) Provides tobacco control legal and policy guidance to government officials, researchers, and advocates at local, state, and federal levels. Drafts public comments on FDA proposed rules and has provided policy advice to NY State DOH and local health departments.
- Trinkets & Trash (T&T) Surveillance System A surveillance system and archive that monitors, collects, and documents current and historic tobacco products and tobacco industry marketing materials and tactics for research and educational purposes.
- Tobacco Treatment Specialist (TTS) Training A Council for Tobacco Treatment Training Programs (CTTTP) nationally accredited training program for tobacco treatment specialists. Over 3,000 clinicians trained from all 50 states and over 11 countries.
- NJ Youth Tobacco Survey (NJYTS) Statewide survey measuring the use of cigarettes, cigars, smokeless tobacco, snus, hookah, electronic cigarettes, and nicotine pouches among New Jersey youth. Reports prepared for the NJ Department of Health.
- NJ Point-of-Sale Reports Annual reports tracking tobacco product marketing and sales at point-of-sale locations in New Jersey from 2014-2025.
Quantifiable outcome
- Over 7,000 smokers treated in New Jersey
- +2 more outcomes
Companies that use Rutgers Institute for Nicotine and Tobacco Studies (INTS)
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles5 records
Rutgers Institute for Nicotine and Tobacco Studies (INTS) technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Rutgers Institute for Nicotine and Tobacco Studies (INTS) partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core, major and minor.
- Wake Forest UniversitycoreWake Forest University is a co-investigator institution on the $18 million CRST (Center of Excellence for Rapid Surveillance of Tobacco) grant, contributing to rapid surveillance of tobacco product marketing, marketplace, and use behaviors.
- Stanford UniversitycoreStanford University is a co-investigator institution on the CRST grant, participating in tobacco surveillance research activities.
- University of KentuckycoreUniversity of Kentucky is a co-investigator institution on the CRST grant, contributing to tobacco surveillance research.
- The Ohio State UniversitycoreThe Ohio State University is a co-investigator institution on the CRST grant, participating in tobacco surveillance activities.
- Columbia UniversitycoreColumbia University is a co-investigator institution on the CRST grant, contributing to tobacco surveillance research.
- Westat, Inc.coreWestat, Inc. is a co-investigator institution on the CRST grant, providing research support for tobacco surveillance.
- University of PennsylvaniacoreUniversity of Pennsylvania was co-lead institution with Rutgers on the $18 million TCORS 2.0 grant (2018-2025), led by Andrew Strasser and Cristine Delnevo as MPIs, studying effects of tobacco marketing, labeling, and packaging.
- University of Michigan (Center for the Assessment of Tobacco Regulations - CAsToR)coreCAsToR at University of Michigan is the lead center for TCORS 3.0 (2025-2028), funded to provide evidence-based modeling of behavioral and public health impacts of FDA tobacco rules. Dr. Rafael Meza joined Rutgers from Michigan in September 2025.
- Public Health Law CentercoreThrough a subcontract with the Public Health Law Center, TCLPRC has provided tobacco control policy advice to the New York State Department of Health and various local health departments.
- New York State Department of HealthmajorTCLPRC, through its subcontract with Public Health Law Center, has provided tobacco control policy advice to the New York State Department of Health and local health departments.
- New York City Law DepartmentminorTCLPRC collaborated with the New York City Law Department regarding the study of illicit trade of untaxed cigarettes and illicit e-cigarettes.
- FDA (Food and Drug Administration)coreINTS serves as a key research partner for FDA's tobacco regulatory science program. TCLPRC drafts and coordinates public comments on FDA proposed rules. TCORS generates research to inform FDA regulation of tobacco products.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Rutgers Institute for Nicotine and Tobacco Studies (INTS) competitors and assessment
Company assessmentOthers
- American Lung Association: National public health nonprofit that funds tobacco cessation research, advocacy, and policy. Comparable as an adjacent ecosystem actor that translates tobacco science into public education and state/federal policy, but operates as an advocacy/funding body rather than a research institute.
- CDC Office on Smoking and Health: Federal public health office that conducts surveillance (e.g., National Youth Tobacco Survey), funds state tobacco control programs, and sets national tobacco priorities. Comparable as a tobacco surveillance and policy translation entity and as a key partner/funder for INTS-style academic research.
- Society for Research on Nicotine and Tobacco (SRNT): International scientific society that convenes INTS and the broader nicotine/tobacco research community, including the SRNT Annual Meeting where INTS faculty and staff present 70+ talks. Comparable as the central convening body for INTS' field rather than a direct research competitor.
Direct peers
- UCSF Center for Tobacco Control Research and Education: One of the longest-standing academic tobacco research centers in the U.S., publishing and training across tobacco control, policy, and cessation. Directly comparable to INTS as a university-based research hub producing evidence that informs FDA and state tobacco regulation.
- University of Pennsylvania (TCORS / tobacco regulatory science): Co-lead with Rutgers on the $18M TCORS 2.0 grant (2018-2025) studying tobacco marketing, labeling, and packaging. Directly comparable in TCORS scope, federal funding scale, and regulatory science focus.
- University of Michigan Center for the Assessment of Tobacco Regulations (CAsToR): Lead center of TCORS 3.0 (2025-2028) and a direct collaborator with INTS on FDA tobacco regulatory science modeling. Comparable as a TCORS-affiliated academic center doing FDA-funded behavioral and public health modeling of tobacco regulations.
- Wake Forest University School of Medicine (CRST co-investigator): Academic co-investigator on INTS' $18M CRST grant for rapid surveillance of tobacco. Directly comparable as a peer university research group collaborating on FDA-funded tobacco surveillance and regulatory science.
- Georgetown University Medical Center (TCORS): Another TCORS-affiliated academic center conducting FDA-funded research on tobacco product regulations. Directly comparable as a competing TCORS site pursuing similar federal regulatory science grants.
- Truth Initiative Schroeder Institute: Research arm of Truth Initiative focused on tobacco use surveillance, cessation, and policy evaluation. Directly comparable to INTS in combining population-level surveillance (e.g., Monitoring the Future/MYSTIC-style products), cessation research, and policy translation.
Broad incumbents
- Roswell Park Comprehensive Cancer Center: Large NCI-designated cancer center with significant tobacco and nicotine research programs. Comparable as a broader, well-established research institution that addresses tobacco use as one pillar of a wider cancer control portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Rutgers Institute for Nicotine and Tobacco Studies (INTS) social profiles
Digital presenceRutgers Institute for Nicotine and Tobacco Studies (INTS) financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rutgers Institute for Nicotine and Tobacco Studies (INTS) leadership team
Management profileNumber of profiles
Profiles5 records
Rutgers Institute for Nicotine and Tobacco Studies (INTS) subsidiaries and ownership
Company hierarchySubsidiaries5 records
Rutgers Institute for Nicotine and Tobacco Studies (INTS) funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rutgers Institute for Nicotine and Tobacco Studies (INTS) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rutgers Institute for Nicotine and Tobacco Studies (INTS)
What does Rutgers Institute for Nicotine and Tobacco Studies (INTS) do?
The Rutgers Institute for Nicotine and Tobacco Studies (INTS) is a research institute that conducts tobacco control research, delivers evidence-based tobacco dependence treatment, trains clinicians as tobacco treatment specialists, and provides legal/policy guidance to government agencies. It operates five specialized centers (TCORS, CRST, TDP, TIM, TCLPRC) plus a central Office of Survey Methods and Data Analysis (SMDA).
Is Rutgers Institute for Nicotine and Tobacco Studies (INTS) a public or private company?
Rutgers Institute for Nicotine and Tobacco Studies (INTS) is a private company. It is classified as state government owned and is currently operating.
When was Rutgers Institute for Nicotine and Tobacco Studies (INTS) founded?
Rutgers Institute for Nicotine and Tobacco Studies (INTS) was founded in 2000. It employs 11 to 50 people.
Where is Rutgers Institute for Nicotine and Tobacco Studies (INTS) based?
Rutgers Institute for Nicotine and Tobacco Studies (INTS) is headquartered in New Brunswick, United States, in the North America region.
How does Rutgers Institute for Nicotine and Tobacco Studies (INTS) make money?
One revenue line is on record: extramural Research Funding.
Who are Rutgers Institute for Nicotine and Tobacco Studies (INTS)'s main competitors?
Others on record are American Lung Association, CDC Office on Smoking and Health and Society for Research on Nicotine and Tobacco (SRNT). Direct peers are UCSF Center for Tobacco Control Research and Education, University of Pennsylvania (TCORS / tobacco regulatory science), University of Michigan Center for the Assessment of Tobacco Regulations (CAsToR), Wake Forest University School of Medicine (CRST co-investigator), Georgetown University Medical Center (TCORS) and Truth Initiative Schroeder Institute. Roswell Park Comprehensive Cancer Center is listed as a broad incumbent.
Does Rutgers Institute for Nicotine and Tobacco Studies (INTS) have an API?
No public API is recorded for Rutgers Institute for Nicotine and Tobacco Studies (INTS).
What industry is Rutgers Institute for Nicotine and Tobacco Studies (INTS) in?
Rutgers Institute for Nicotine and Tobacco Studies (INTS)'s product category is Tobacco Control Research and Public Health. Its primary akta.pro industry code is EDAHAAAC, Public Research Universities with Academic Medical Centers (AMCs), with a secondary code of EDADAKAH, Research Administration & Compliance (Sponsored Programs, IRB/REB). Its NAICS code is 5417 and its SIC code is 8731.